{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:37:03Z","timestamp":1792705023369,"version":"4.5.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,3,18]],"date-time":"2011-03-18T00:00:00Z","timestamp":1300406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s10620-011-1619-9","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T06:23:26Z","timestamp":1300343006000},"page":"1266-1281","source":"Crossref","is-referenced-by-count":13,"title":["The Management of Hospitalized Patients with Cirrhosis: The Mount Sinai Experience and a Guide for Hospitalists"],"prefix":"10.1007","volume":"56","author":[{"given":"Ponni V.","family":"Perumalswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,18]]},"reference":[{"key":"1619_CR1","first-page":"1","volume":"53","author":"KD Kochanek","year":"2004","unstructured":"Kochanek KD, Murphy SL, Anderson RN, Scott C. Deaths: final data for 2002. Natl Vital Stat Rep. 2004;53:1\u2013115.","journal-title":"Natl Vital Stat Rep"},{"key":"1619_CR2","first-page":"24","volume":"13","author":"CJ DeFrances","year":"2007","unstructured":"DeFrances CJ, Cullen KA, Kozak LJ. National hospital discharge survey: 2005 Annual summary with detailed diagnosis and procedure data. Vital Health Stat. 2007;13:24.","journal-title":"Vital Health Stat"},{"key":"1619_CR3","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1742-1241.2007.01423.x","volume":"61","author":"ME Falagas","year":"2007","unstructured":"Falagas ME, Vardakas KZ, Vergidis PI. Under-diagnosis of common chronic diseases: prevalence and impact on human health. Int J Clin Pract. 2007;61:1569\u20131579.","journal-title":"Int J Clin Pract"},{"key":"1619_CR4","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL. Liver fibrosis\u2014from bench to bedside. J Hepatol. 2003;38:S38\u2013S53.","journal-title":"J Hepatol"},{"key":"1619_CR5","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/hep.1840360705","volume":"36","author":"WR Kim","year":"2002","unstructured":"Kim WR. The burden of hepatitis C in the United States. Hepatology. 2002;36:S30\u2013S34.","journal-title":"Hepatology"},{"key":"1619_CR6","doi-asserted-by":"crossref","unstructured":"Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis. 1997;1:559\u2013568, vi\u2013vii.","DOI":"10.1016\/S1089-3261(05)70321-4"},{"key":"1619_CR7","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199212313272703","volume":"327","author":"LB Seeff","year":"1992","unstructured":"Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med. 1992;327:1906\u20131911.","journal-title":"N Engl J Med"},{"key":"1619_CR8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jlts.2003.50073","volume":"9","author":"GL Davis","year":"2003","unstructured":"Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003;9:331\u2013338.","journal-title":"Liver Transpl"},{"key":"1619_CR9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.23561","volume":"51","author":"AE Mitchell","year":"2010","unstructured":"Mitchell AE, Colvin HM, Palmer Beasley R. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology. 2010;51:729\u2013733.","journal-title":"Hepatology"},{"key":"1619_CR10","unstructured":"United Network of Organ Sharing (UNOS). UNOS database."},{"key":"1619_CR11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMcp052967","volume":"355","author":"GM Arepally","year":"2006","unstructured":"Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2006;355:809\u2013817.","journal-title":"N Engl J Med"},{"key":"1619_CR12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-136-3-200202050-00009","volume":"136","author":"L Rice","year":"2002","unstructured":"Rice L, Attisha WK, Drexler A, Francis JL. Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med. 2002;136:210\u2013215.","journal-title":"Ann Intern Med"},{"key":"1619_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2002-23205","volume":"22","author":"L Amitrano","year":"2002","unstructured":"Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis. 2002;22:83\u201396.","journal-title":"Semin Liver Dis"},{"key":"1619_CR14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0030-1253227","volume":"30","author":"A Kosters","year":"2010","unstructured":"Kosters A, Karpen SJ. The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis. 2010;30:186\u2013194.","journal-title":"Semin Liver Dis"},{"key":"1619_CR15","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1538-7836.2010.03877.x","volume":"8","author":"A Tripodi","year":"2010","unstructured":"Tripodi A, Baglin T, Robert A, et al. Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease. J Thromb Haemost. 2010;8:1410\u20131412.","journal-title":"J Thromb Haemost"},{"key":"1619_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","volume":"52","author":"C Francoz","year":"2010","unstructured":"Francoz C, Glotz D, Moreau R, Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol. 2010;52:605\u2013613.","journal-title":"J Hepatol"},{"key":"1619_CR17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4065\/84.2.170","volume":"84","author":"S Goldfarb","year":"2009","unstructured":"Goldfarb S, McCullough PA, McDermott J, Gay SB. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc. 2009;84:170\u2013179.","journal-title":"Mayo Clin Proc"},{"key":"1619_CR18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","volume":"343","author":"M Tepel","year":"2000","unstructured":"Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180\u2013184.","journal-title":"N Engl J Med"},{"key":"1619_CR19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2214\/AJR.06.1094","volume":"188","author":"DR Broome","year":"2007","unstructured":"Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol. 2007;188:586\u2013592.","journal-title":"AJR Am J Roentgenol"},{"key":"1619_CR20","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.2009.193227","volume":"59","author":"M Rossle","year":"2010","unstructured":"Rossle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut. 2010;59:988\u20131000.","journal-title":"Gut"},{"key":"1619_CR21","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJM199505043321803","volume":"332","author":"A Ochs","year":"1995","unstructured":"Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med. 1995;332:1192\u20131197.","journal-title":"N Engl J Med"},{"key":"1619_CR22","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1053\/gast.1997.v113.pm9352865","volume":"113","author":"P Sauer","year":"1997","unstructured":"Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology. 1997;113:1623\u20131631.","journal-title":"Gastroenterology"},{"key":"1619_CR23","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/0016-5085(94)90020-5","volume":"106","author":"CD Lind","year":"1994","unstructured":"Lind CD, Malisch TW, Chong WK, et al. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology. 1994;106:1277\u20131283.","journal-title":"Gastroenterology"},{"key":"1619_CR24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1148\/radiology.191.1.8134566","volume":"191","author":"KA Hausegger","year":"1994","unstructured":"Hausegger KA, Sternthal HM, Klein GE, Karaic R, Stauber R, Zenker G. Transjugular intrahepatic portosystemic shunt: angiographic follow-up and secondary interventions. Radiology. 1994;191:177\u2013181.","journal-title":"Radiology"},{"key":"1619_CR25","doi-asserted-by":"crossref","unstructured":"Forster J, Siegel EL, Delcore R, Payne KM, Laurin J, Kindscher JD. Is the role of transjugular intrahepatic portosystemic shunts limited in the management of patients with end-stage liver disease? Am J Surg. 1996;172:536\u2013539; discussion 539-40.","DOI":"10.1016\/S0002-9610(96)00239-5"},{"key":"1619_CR26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1478-3231.2007.01522.x","volume":"27","author":"C Bureau","year":"2007","unstructured":"Bureau C, Pagan JC, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int. 2007;27:742\u2013747.","journal-title":"Liver Int"},{"key":"1619_CR27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","volume":"126","author":"C Bureau","year":"2004","unstructured":"Bureau C, Garcia-Pagan JC, Otal P, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469\u2013475.","journal-title":"Gastroenterology"},{"key":"1619_CR28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00270-009-9696-2","volume":"33","author":"A Kovacs","year":"2010","unstructured":"Kovacs A, Schepke M, Heller J, Schild HH, Flacke S. Short-term effects of transjugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results. Cardiovasc Intervent Radiol. 2010;33:290\u2013296.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1619_CR29","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/j.1572-0241.2003.08662.x","volume":"98","author":"J Browning","year":"2003","unstructured":"Browning J, Combes B, Mayo MJ. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol. 2003;98:2736\u20132741.","journal-title":"Am J Gastroenterol"},{"key":"1619_CR30","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","volume":"45","author":"MJ Mayo","year":"2007","unstructured":"Mayo MJ, Handem I, Saldana S, Jacobe H, Getachew Y, Rush AJ. Sertraline as a first-line treatment for cholestatic pruritus. Hepatology. 2007;45:666\u2013674.","journal-title":"Hepatology"},{"key":"1619_CR31","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2165\/00003495-200868150-00006","volume":"68","author":"AE Kremer","year":"2008","unstructured":"Kremer AE, Beuers U, Oude-Elferink RP, Pusl T. Pathogenesis and treatment of pruritus in cholestasis. Drugs. 2008;68:2163\u20132182.","journal-title":"Drugs"},{"key":"1619_CR32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11894-999-0119-y","volume":"1","author":"JC Teran","year":"1999","unstructured":"Teran JC. Nutrition and liver diseases. Curr Gastroenterol Rep. 1999;1:335\u2013340.","journal-title":"Curr Gastroenterol Rep"},{"key":"1619_CR33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.mjt.0000140216.40700.95","volume":"12","author":"GD Benson","year":"2005","unstructured":"Benson GD, Koff RS, Tolman KG. The therapeutic use of acetaminophen in patients with liver disease. Am J Ther. 2005;12:133\u2013141.","journal-title":"Am J Ther"},{"key":"1619_CR34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4065\/mcp.2009.0534","volume":"85","author":"N Chandok","year":"2010","unstructured":"Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc. 2010;85:451\u2013458.","journal-title":"Mayo Clin Proc"},{"key":"1619_CR35","first-page":"530","volume":"17","author":"G Laffi","year":"1997","unstructured":"Laffi G, La Villa G, Pinzani M, Marra F, Gentilini P. Arachidonic acid derivatives and renal function in liver cirrhosis. Semin Nephrol. 1997;17:530\u2013548.","journal-title":"Semin Nephrol"},{"key":"1619_CR36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cgh.2009.03.020","volume":"7","author":"RP Myers","year":"2009","unstructured":"Myers RP, Shaheen AA, Hubbard JN, Kaplan GG. Characteristics of patients with cirrhosis who are discharged from the hospital against medical advice. Clin Gastroenterol Hepatol. 2009;7:786\u2013792.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1619_CR37","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","volume":"139","author":"V Arvaniti","year":"2010","unstructured":"Arvaniti V, D\u2019Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality 4-fold and should be used in determining prognosis. Gastroenterology. 2010;139:1246\u20131256.","journal-title":"Gastroenterology"},{"key":"1619_CR38","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00007611-199710000-00014","volume":"90","author":"CM Vollberg","year":"1997","unstructured":"Vollberg CM, Herrera JL. Vibrio vulnificus infection: an important cause of septicemia in patients with cirrhosis. South Med J. 1997;90:1040\u20131042.","journal-title":"South Med J"},{"key":"1619_CR39","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/514947","volume":"27","author":"WC Ko","year":"1998","unstructured":"Ko WC, Chuang YC, Huang GC, Hsu SY. Infections due to non-O1 Vibrio cholerae in southern Taiwan: predominance in cirrhotic patients. Clin Infect Dis. 1998;27:774\u2013780.","journal-title":"Clin Infect Dis"},{"key":"1619_CR40","first-page":"1937","volume-title":"Section\u00a09: Liver. Sleisenger and Fordtran\u2019s gastrointestinal and liver disease: pathophysiology, diagnosis, management","author":"M Feldman","year":"2006","unstructured":"Feldman M, Friedman LS, Brandt LJ. Section\u00a09: Liver. Sleisenger and Fordtran\u2019s gastrointestinal and liver disease: pathophysiology, diagnosis, management. 8th ed. Philadelphia: Elsevier Health Sciences; 2006:1937.","edition":"8"},{"key":"1619_CR41","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/hep.22418","volume":"48","author":"P Gines","year":"2008","unstructured":"Gines P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008;48:1002\u20131010.","journal-title":"Hepatology"},{"key":"1619_CR42","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","volume":"124","author":"AL Gerbes","year":"2003","unstructured":"Gerbes AL, Gulberg V, Gines P, et al. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology. 2003;124:933\u2013939.","journal-title":"Gastroenterology"},{"key":"1619_CR43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.22293","volume":"48","author":"P Gines","year":"2008","unstructured":"Gines P, Wong F, Watson H, et al. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology. 2008;48:204\u2013213.","journal-title":"Hepatology"},{"key":"1619_CR44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","volume":"35","author":"J Fernandez","year":"2002","unstructured":"Fernandez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140\u2013148.","journal-title":"Hepatology"},{"key":"1619_CR45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","volume":"32","author":"A Rimola","year":"2000","unstructured":"Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000;32:142\u2013153.","journal-title":"J Hepatol"},{"key":"1619_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0011-5029(85)90002-1","volume":"31","author":"JC Hoefs","year":"1985","unstructured":"Hoefs JC, Runyon BA. Spontaneous bacterial peritonitis. Dis Mon. 1985;31:1\u201348.","journal-title":"Dis Mon"},{"key":"1619_CR47","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3346\/jkms.2006.21.4.666","volume":"21","author":"JY Song","year":"2006","unstructured":"Song JY, Jung SJ, Park CW, et al. Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired. J Korean Med Sci. 2006;21:666\u2013671.","journal-title":"J Korean Med Sci"},{"key":"1619_CR48","first-page":"1232","volume":"96","author":"PJ Thuluvath","year":"2001","unstructured":"Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis\u2014in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol. 2001;96:1232\u20131236.","journal-title":"Am J Gastroenterol"},{"key":"1619_CR49","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/gut.4.4.394","volume":"4","author":"DN Kerr","year":"1963","unstructured":"Kerr DN, Pearson DT, Read AE. Infection of ascitic fluid in patients with hepatic cirrhosis. Gut. 1963;4:394\u2013398.","journal-title":"Gut"},{"key":"1619_CR50","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/0003-4819-60-4-568","volume":"60","author":"HO Conn","year":"1964","unstructured":"Conn HO. Spontaneous peritonitis and bacteremia in Laennec\u2019s cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome. Ann Intern Med. 1964;60:568\u2013580.","journal-title":"Ann Intern Med"},{"key":"1619_CR51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.1840080107","volume":"8","author":"L Tito","year":"1988","unstructured":"Tito L, Rimola A, Gines P, Llach J, Arroyo V, Rodes J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology. 1988;8:27\u201331.","journal-title":"Hepatology"},{"key":"1619_CR52","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2004.09.001","volume":"41","author":"G Garcia-Tsao","year":"2004","unstructured":"Garcia-Tsao G. Spontaneous bacterial peritonitis: a historical perspective. J Hepatol. 2004;41:522\u2013527.","journal-title":"J Hepatol"},{"key":"1619_CR53","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","volume":"20","author":"A Follo","year":"1994","unstructured":"Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology. 1994;20:1495\u20131501.","journal-title":"Hepatology"},{"key":"1619_CR54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403\u2013409.","journal-title":"N Engl J Med"},{"key":"1619_CR55","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0016-5085(90)91305-P","volume":"98","author":"P Cales","year":"1990","unstructured":"Cales P, Zabotto B, Meskens C, et al. Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction. Gastroenterology. 1990;98:156\u2013162.","journal-title":"Gastroenterology"},{"key":"1619_CR56","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.1840220145","volume":"22","author":"G D\u2019Amico","year":"1995","unstructured":"D\u2019Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332\u2013354.","journal-title":"Hepatology"},{"key":"1619_CR57","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/MEG.0b013e32830280c7","volume":"20","author":"MM Jamal","year":"2008","unstructured":"Jamal MM, Samarasena JB, Hashemzadeh M. Decreasing in-hospital mortality for oesophageal variceal hemorrhage in the USA. Eur J Gastroenterol Hepatol. 2008;20:947\u2013955.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1619_CR58","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.49.5.682","volume":"49","author":"PA McCormick","year":"2001","unstructured":"McCormick PA, O\u2019Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut. 2001;49:682\u2013685.","journal-title":"Gut"},{"key":"1619_CR59","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0016-5085(81)90144-X","volume":"80","author":"DY Graham","year":"1981","unstructured":"Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80:800\u2013809.","journal-title":"Gastroenterology"},{"key":"1619_CR60","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/gut.2004.048181","volume":"54","author":"U Thalheimer","year":"2005","unstructured":"Thalheimer U, Triantos CK, Samonakis DN, Patch D, Burroughs AK. Infection, coagulation, and variceal bleeding in cirrhosis. Gut. 2005;54:556\u2013563.","journal-title":"Gut"},{"key":"1619_CR61","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0016-5085(01)81028-3","volume":"121","author":"JC Garcia-Pagan","year":"2001","unstructured":"Garcia-Pagan JC, Villanueva C, Vila MC, et al. Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers. Gastroenterology. 2001;121:908\u2013914.","journal-title":"Gastroenterology"},{"key":"1619_CR62","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.gie.2008.02.068","volume":"67","author":"S Banerjee","year":"2008","unstructured":"ASGE STANDARDS OF PRACTICE COMMITTEE, Banerjee S, Shen B, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008;67:791\u2013798.","journal-title":"Gastrointest Endosc"},{"key":"1619_CR63","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1537-2995.1985.25686071434.x","volume":"25","author":"MA Popovsky","year":"1985","unstructured":"Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25:573\u2013577.","journal-title":"Transfusion"},{"key":"1619_CR64","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1046\/j.1537-2995.2001.41101244.x","volume":"41","author":"PM Kopko","year":"2001","unstructured":"Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion. 2001;41:1244\u20131248.","journal-title":"Transfusion"},{"key":"1619_CR65","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00000542-199503000-00024","volume":"82","author":"JG Weber","year":"1995","unstructured":"Weber JG, Warner MA, Moore SB. What is the incidence of perioperative transfusion-related acute lung injury? Anesthesiology. 1995;82:789.","journal-title":"Anesthesiology"},{"key":"1619_CR66","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1537-2995.1992.32692367207.x","volume":"32","author":"MA Popovsky","year":"1992","unstructured":"Popovsky MA, Chaplin HC Jr, Moore SB. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion. 1992;32:589\u2013592.","journal-title":"Transfusion"},{"key":"1619_CR67","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2002-03-0958","volume":"101","author":"CC Silliman","year":"2003","unstructured":"Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101:454\u2013462.","journal-title":"Blood"},{"key":"1619_CR68","first-page":"270","volume":"104","author":"JE Menitove","year":"2007","unstructured":"Menitove JE. Transfusion related acute lung injury (TRALI): a review. Mo Med. 2007;104:270\u2013275.","journal-title":"Mo Med"},{"key":"1619_CR69","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3748\/wjg.15.1459","volume":"15","author":"N Lodhia","year":"2009","unstructured":"Lodhia N, Kader M, Mayes T, Mantry P, Maliakkal B. Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis. World J Gastroenterol. 2009;15:1459\u20131464.","journal-title":"World J Gastroenterol"},{"key":"1619_CR70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ajg.2008.34","volume":"104","author":"KK Sogaard","year":"2009","unstructured":"Sogaard KK, Horvath-Puho E, Gronbaek H, Jepsen P, Vilstrup H, Sorensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol. 2009;104:96\u2013101.","journal-title":"Am J Gastroenterol"},{"key":"1619_CR71","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.510230516","volume":"23","author":"M Merli","year":"1996","unstructured":"Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology. 1996;23:1041\u20131046.","journal-title":"Hepatology"},{"key":"1619_CR72","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/hep.1840150507","volume":"15","author":"MJ Muller","year":"1992","unstructured":"Muller MJ, Lautz HU, Plogmann B, Burger M, Korber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology. 1992;15:782\u2013794.","journal-title":"Hepatology"},{"key":"1619_CR73","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ajcn\/63.4.602","volume":"63","author":"L Caregaro","year":"1996","unstructured":"Caregaro L, Alberino F, Amodio P, et al. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr. 1996;63:602\u2013609.","journal-title":"Am J Clin Nutr"},{"key":"1619_CR74","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/jlts.2000.9736","volume":"6","author":"FA Figueiredo","year":"2000","unstructured":"Figueiredo FA, Dickson ER, Pasha TM, et al. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl. 2000;6:575\u2013581.","journal-title":"Liver Transpl"},{"key":"1619_CR75","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0899-9007(01)00626-8","volume":"17","author":"C Roongpisuthipong","year":"2001","unstructured":"Roongpisuthipong C, Sobhonslidsuk A, Nantiruj K, Songchitsomboon S. Nutritional assessment in various stages of liver cirrhosis. Nutrition. 2001;17:761\u2013765.","journal-title":"Nutrition"},{"key":"1619_CR76","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/hep.510290531","volume":"29","author":"HI Davidson","year":"1999","unstructured":"Davidson HI, Richardson R, Sutherland D, Garden OJ. Macronutrient preference, dietary intake, and substrate oxidation among stable cirrhotic patients. Hepatology. 1999;29:1380\u20131386.","journal-title":"Hepatology"},{"key":"1619_CR77","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ajcn\/69.2.331","volume":"69","author":"RA Richardson","year":"1999","unstructured":"Richardson RA, Davidson HI, Hinds A, Cowan S, Rae P, Garden OJ. Influence of the metabolic sequelae of liver cirrhosis on nutritional intake. Am J Clin Nutr. 1999;69:331\u2013337.","journal-title":"Am J Clin Nutr"},{"key":"1619_CR78","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0899-9007(01)00521-4","volume":"17","author":"F Alberino","year":"2001","unstructured":"Alberino F, Gatta A, Amodio P, et al. Nutrition and survival in patients with liver cirrhosis. Nutrition. 2001;17:445\u2013450.","journal-title":"Nutrition"},{"key":"1619_CR79","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00007890-199402150-00030","volume":"57","author":"J Pikul","year":"1994","unstructured":"Pikul J, Sharpe MD, Lowndes R, Ghent CN. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation. 1994;57:469\u2013472.","journal-title":"Transplantation"},{"key":"1619_CR80","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.510250327","volume":"25","author":"O Selberg","year":"1997","unstructured":"Selberg O, Bottcher J, Tusch G, Pichlmayr R, Henkel E, Muller MJ. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology. 1997;25:652\u2013657.","journal-title":"Hepatology"},{"key":"1619_CR81","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/hep.1840150507","volume":"15","author":"MJ Muller","year":"1992","unstructured":"Muller MJ, Lautz HU, Plogmann B, Burger M, Korber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology. 1992;15:782\u2013794.","journal-title":"Hepatology"},{"key":"1619_CR82","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1432-2277.1997.tb00931.x","volume":"10","author":"J Harrison","year":"1997","unstructured":"Harrison J, McKiernan J, Neuberger JM. A prospective study on the effect of recipient nutritional status on outcome in liver transplantation. Transpl Int. 1997;10:369\u2013374.","journal-title":"Transpl Int"},{"key":"1619_CR83","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9343(99)00217-X","volume":"107","author":"KN Lazaridis","year":"1999","unstructured":"Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med. 1999;107:262\u2013267.","journal-title":"Am J Med"},{"key":"1619_CR84","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00063198-199807000-00011","volume":"4","author":"X Xiol","year":"1998","unstructured":"Xiol X, Guardiola J. Hepatic hydrothorax. Curr Opin Pulm Med. 1998;4:239\u2013242.","journal-title":"Curr Opin Pulm Med"},{"key":"1619_CR85","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00063198-200307000-00003","volume":"9","author":"GT Kinasewitz","year":"2003","unstructured":"Kinasewitz GT, Keddissi JI. Hepatic hydrothorax. Curr Opin Pulm Med. 2003;9:261\u2013265.","journal-title":"Curr Opin Pulm Med"},{"key":"1619_CR86","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1378\/chest.126.1.142","volume":"126","author":"LU Liu","year":"2004","unstructured":"Liu LU, Haddadin HA, Bodian CA, et al. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest. 2004;126:142\u2013148.","journal-title":"Chest"},{"key":"1619_CR87","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","volume":"94","author":"DM Parkin","year":"2001","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153\u2013156.","journal-title":"Int J Cancer"},{"key":"1619_CR88","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/S1051-0443(07)61783-7","volume":"13","author":"AM Di Bisceglie","year":"2002","unstructured":"Di Bisceglie AM. Epidemiology and clinical presentation of hepatocellular carcinoma. J Vasc Interv Radiol. 2002;13:S169\u2013S171.","journal-title":"J Vasc Interv Radiol"},{"key":"1619_CR89","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","volume":"340","author":"HB El-Serag","year":"1999","unstructured":"El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745\u2013750.","journal-title":"N Engl J Med"},{"key":"1619_CR90","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/bmj.319.7210.640","volume":"319","author":"SD Taylor-Robinson","year":"1999","unstructured":"Taylor-Robinson SD, Thomas HC, Arora S, Hargreaves S. Increased mortality from liver cancer in England and Wales is not related to hepatitis C. BMJ. 1999;319:640.","journal-title":"BMJ"},{"key":"1619_CR91","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","volume":"37","author":"SA Khan","year":"2002","unstructured":"Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002;37:806\u2013813.","journal-title":"J Hepatol"},{"key":"1619_CR92","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1001\/archinte.160.21.3227","volume":"160","author":"HB El-Serag","year":"2000","unstructured":"El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med. 2000;160:3227\u20133230.","journal-title":"Arch Intern Med"},{"key":"1619_CR93","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.sla.0000143301.56154.95","volume":"240","author":"V Mazzaferro","year":"2004","unstructured":"Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg. 2004;240:900\u2013909.","journal-title":"Ann Surg"},{"key":"1619_CR94","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1053\/jlts.2002.36394","volume":"8","author":"RJ Fontana","year":"2002","unstructured":"Fontana RJ, Hamidullah H, Nghiem H, et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl. 2002;8:1165\u20131174.","journal-title":"Liver Transpl"},{"key":"1619_CR95","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/jhep.2002.35071","volume":"36","author":"MF Yuen","year":"2002","unstructured":"Yuen MF, Poon RT, Lai CL, et al. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Hepatology. 2002;36:687\u2013691.","journal-title":"Hepatology"},{"key":"1619_CR96","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1053\/j.gastro.2004.09.032","volume":"127","author":"J Bruix","year":"2004","unstructured":"Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology. 2004;127:S179\u2013S188.","journal-title":"Gastroenterology"},{"key":"1619_CR97","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","volume":"37","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429\u2013442.","journal-title":"Hepatology"},{"key":"1619_CR98","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"JM Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734\u20131739.","journal-title":"Lancet"},{"key":"1619_CR99","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1097\/01.tp.0000187109.69663.93","volume":"80","author":"A Lubienski","year":"2005","unstructured":"Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation. 2005;80:S113\u2013S119.","journal-title":"Transplantation"},{"key":"1619_CR100","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix J, Sherman M. Practice guidelines committee, American association for the study of liver diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208\u20131236.","journal-title":"Hepatology"},{"key":"1619_CR101","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1572-0241.2001.03964.x","volume":"96","author":"AT Blei","year":"2001","unstructured":"Blei AT, Cordoba J. Practice parameters committee of the American college of gastroenterology. Hepatic encephalopathy. Am J Gastroenterol. 2001;96:1968\u20131976.","journal-title":"Am J Gastroenterol"},{"key":"1619_CR102","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM199708143370707","volume":"337","author":"SM Riordan","year":"1997","unstructured":"Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med. 1997;337:473\u2013479.","journal-title":"N Engl J Med"},{"key":"1619_CR103","first-page":"890","volume":"1","author":"J Bircher","year":"1966","unstructured":"Bircher J, Muller J, Guggenheim P, Haemmerli UP. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet. 1966;1:890\u2013892.","journal-title":"Lancet"},{"key":"1619_CR104","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","volume":"72","author":"HO Conn","year":"1977","unstructured":"Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology. 1977;72:573\u2013583.","journal-title":"Gastroenterology"},{"key":"1619_CR105","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF01072921","volume":"23","author":"CE Atterbury","year":"1978","unstructured":"Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis. 1978;23:398\u2013406.","journal-title":"Am J Dig Dis"},{"key":"1619_CR106","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4615-1989-8_13","volume":"368","author":"RA Hawkins","year":"1994","unstructured":"Hawkins RA, Jessy J, Mans AM, Chedid A, DeJoseph MR. Neomycin reduces the intestinal production of ammonia from glutamine. Adv Exp Med Biol. 1994;368:125\u2013134.","journal-title":"Adv Exp Med Biol"},{"key":"1619_CR107","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/0002-9343(79)90649-1","volume":"67","author":"PH Green","year":"1979","unstructured":"Green PH, Tall AR. Drugs, alcohol and malabsorption. Am J Med. 1979;67:1066\u20131076.","journal-title":"Am J Med"},{"key":"1619_CR108","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2146\/ajhp070298","volume":"65","author":"RT Melo de","year":"2008","unstructured":"de Melo RT, Charneski L, Hilas O. Rifaximin for the treatment of hepatic encephalopathy. Am J Health Syst Pharm. 2008;65:818\u2013822.","journal-title":"Am J Health Syst Pharm"},{"key":"1619_CR109","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","volume":"362","author":"NM Bass","year":"2010","unstructured":"Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362:1071\u20131081.","journal-title":"N Engl J Med"},{"key":"1619_CR110","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","volume":"37","author":"JG Abraldes","year":"2003","unstructured":"Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology. 2003;37:902\u2013908.","journal-title":"Hepatology"},{"key":"1619_CR111","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","volume":"19","author":"G D\u2019Amico","year":"1999","unstructured":"D\u2019Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999;19:475\u2013505.","journal-title":"Semin Liver Dis"},{"key":"1619_CR112","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1572-0241.2006.00453.x","volume":"101","author":"J Turnes","year":"2006","unstructured":"Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell\u2019Era A, Bosch J. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol. 2006;101:506\u2013512.","journal-title":"Am J Gastroenterol"},{"key":"1619_CR113","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","volume":"52","author":"T Serste","year":"2010","unstructured":"Serste T, Melot C, Francoz C, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010;52:1017\u20131022.","journal-title":"Hepatology"},{"key":"1619_CR114","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/hep.20704","volume":"41","author":"KF Murray","year":"2005","unstructured":"Murray KF, Carithers RL Jr. AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology. 2005;41:1407\u20131432.","journal-title":"Hepatology"},{"key":"1619_CR115","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1001\/jama.295.18.2168","volume":"295","author":"AM Larson","year":"2006","unstructured":"Larson AM, Curtis JR. Integrating palliative care for liver transplant candidates: \u201ctoo well for transplant, too sick for life\u201d. JAMA. 2006;295:2168\u20132176.","journal-title":"JAMA"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1619-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-011-1619-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1619-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T11:18:33Z","timestamp":1592392713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-011-1619-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,18]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["1619"],"URL":"https:\/\/doi.org\/10.1007\/s10620-011-1619-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,18]]}}}